Role of gastric leptin and cholecystokinin in patients with functional dyspepsia
Role of gastric leptin and cholecystokinin in patients with functional dyspepsia
批准号:
12670536
负责人:
YOSHIKAWA Ichiro
金额:
$1.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
研究对象为功能性消化不良患者和健康志愿者。患者均给予书面知情同意,接受内窥镜下的血液取样和胃粘膜活检。本研究经我院伦理委员会批准。使用RIA试剂盒检测血浆CCK和瘦素。在内窥镜检查时对基底部位进行活检。瘦素免疫染色采用兔抗人瘦素抗体(a -20, Santa Cruz Biotechnology, California, USA)。血浆CCK和瘦素水平在功能性消化不良患者和健康志愿者之间没有显著差异。在军团上皮腺的下半部分发现瘦素免疫反应细胞。上皮细胞中瘦素阳性染色强度评分为5分。功能性消化不良患者与健康志愿者瘦素阳性染色强度无显著差异。此外,瘦素阳性染色强度在幽门螺杆菌阴性组与阳性组、高(≧23)与低(<23)体重指数组、老年(≧70)与非老年(<70)体重指数组之间无显著差异。胃黏膜瘦素mRNA和十二指肠黏膜CCK mRNA的含量有待进一步测定。
英文摘要
The patients with functional dyspepsia and healthy volunteers were investigated in the study. They all gave written informed consent for blood sampling and gastric mucosal biopsy by endoscopy. This study was approved by the Ethics Committee of our institute. Plasma CCK and leptin were estimated using a RIA kit. Biopsies of fundic sites were performed during endoscopic examination. Immunostaining for leptin was performed by a polyclonal rabbit antihuman leptin antibody (A-20, Santa Cruz Biotechnology, California, USA). Neither plasma CCK nor leptin levels differed significantly between the patients with functional dyspepsia and healthy volunteers. Leptin immunoreactive cells were found in the lower half of the epithelial glands of the corps. Intensity of positive staining for leptin in the epithelial cells was rated on a 5-point score. There was no significant difference in intensity of positive staining for leptin between the patients with functional dyspepsia and healthy volunteers. In addition, there was no significant difference in intensity of positive staining for leptin between the H. pylori-negative and -positive groups, between the high (≧23) and low (<23) levels of body mass index groups or between the aged (≧70) and not aged (<70) groups. Further determination of gastric mucosal leptin mRNA and duodenal mucosal CCK mRNA was required.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
I.Yoshikawa, M.Otsuki, et al.: "Serum pepsinogen can predict response to H2-receptor antagonist in patients with functional dyspepsia"Alimentary Pharmacology and Therapeutics. 16巻・10号. 1805-1809 (2002)
I. Yoshikawa、M. Otsuki 等人:“血清胃蛋白酶原可以预测功能性消化不良患者对 H2 受体拮抗剂的反应”《消化药理学和治疗学》第 16 卷,第 10 期。1805-1809 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshikawa, et al.: "Serum pepsinogen can predict response to H2-receptor antagonist in patients with functional dyspepsia"Alimentary Pharmacology and Therapeutics. 16巻・10号. 1805-1809 (2002)
Yoshikawa 等人:“血清胃蛋白酶原可以预测功能性消化不良患者对 H2 受体拮抗剂的反应”《消化药理学和治疗学》第 16 卷,第 10 期。1805-1809 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ichiro Yoshikawa: "Serum pepsinogen can predict response to H2-receptor antagonist in patients with functional dyspepsia"Alimentary Pharmacology and Therapeutics. 16-10. 1805-1809 (2002)
Ichiro Yoshikawa:“血清胃蛋白酶原可以预测功能性消化不良患者对 H2 受体拮抗剂的反应”《消化药理学和治疗学》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hospital management of Clostridium difficile infection
-
批准号:23591487
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.25万
-
财政年份:2011
-
负责人:YOSHIKAWA Ichiro
-
依托单位:
Development of optics for future EUV astronomy
-
批准号:22540248
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:YOSHIKAWA Ichiro
-
依托单位:
Chewing bicarbonate-containing gum as a treatment option for gastroesophageal reflux disease
-
批准号:17590690
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.59万
-
财政年份:2005
-
负责人:YOSHIKAWA Ichiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Leptin通过调控MxA表达促进CD8+ T细胞活化参与白癜风发生发展的作用机制研究
-
批准号:2026JJ81680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张慧明
-
依托单位:
壳寡糖介导CD44基因通过
LEPTIN/AMPK/SREBP1通路调控牛脂肪代
谢的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:姜平
-
依托单位:
Naringin通过改善Leptin Resistance调节肠上皮AQP3重建糖脂代谢平衡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:周烨
-
依托单位:
基于Leptin/JAK2/STAT3通路探讨针灸传感针治疗肥胖症的中枢机制
-
批准号:JCZRLH202500311
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
膏梁致变"视角下探究健脾化浊法下调Leptin/ObR抑制高脂诱发胃癌前病变的关键机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:曾进浩
-
依托单位:
Leptin通过DKK4/Wnt/β-catenin/PGAM1轴促进结直肠癌进展的机制研究
-
批准号:2024Y9618
-
项目类别:省市级项目
-
资助金额:50.0万元
-
批准年份:2024
-
负责人:卓长华
-
依托单位:
Leptin在呼吸调控异常诱发睡眠呼吸障碍中的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:张俊波
-
依托单位:
“毒粱致变”视角下探究健脾化浊法下调Leptin/ObR抑制毒脂诱发胃癌前病变的关键机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:曾进浩
-
依托单位:
LncTUG1通过miR-29/leptin途径调控角膜新生血管的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
高leptin水平介导HSD17B13对猪肝脏脂代谢影响的机制研究
-
批准号:32360866
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2023
-
负责人:苏艳华
-
依托单位: